Prevalence, risk factors, treatment and outcome of multidrug resistance Candida auris infections in Coronavirus disease (COVID-19) patients: A systematic review.

Vinayagamoorthy, Kalaiselvi; Pentapati, Kalyana Chakravarthy; Prakash, Hariprasath

Vinayagamoorthy, Kalaiselvi; Pentapati, Kalyana Chakravarthy; Prakash, Hariprasath.

Afiliación

Vinayagamoorthy K; Centre for Public Health (U.I.E.A.S.T), Panjab University, Chandigarh, India.
Pentapati KC; Department of Public Health Dentistry, Manipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Prakash H; Medical Microbiology, Department of Public Health, International Higher School of Medicine, Cholpon-Ata, Kyrgyzstan.

Mycoses ; 65(6): 613-624, 2022 Jun.

Article en En | MEDLINE | ID: mdl-35441748

Asunto(s)

COVID-19; Candidemia; Antifúngicos/farmacología; Antifúngicos/uso terapéutico; COVID-19/epidemiología; Candida; Candida auris; Candidemia/tratamiento farmacológico; Candidemia/epidemiología; Resistencia a Múltiples Medicamentos; Humanos; Enfermedad Iatrogénica/epidemiología; Pruebas de Sensibilidad Microbiana; Pandemias; Prevalencia; Factores de Riesgo; Resultado del Tratamiento

Palabras clave

Candida auris; COVID-19; candidemia; mortality; prevalence; systematic review

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Plantas_medicinales Asunto principal: Candidemia / COVID-19 Tipo de estudio: Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Mycoses Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google